Tailored RWD Solutions 

GENIE provides a flexible service model tailored to meet the specific needs of industry partners: 

• Retrospective Data Collection: Clinico-genomic data aggregation, biospecimen access (e.g., DNA or RNA for association studies), and image analytes (e.g., WSI and DICOM images). 
• Prospective Evidence Generation: Custom study designs for de novo data collection. 

Rare Variants and Rare Disease Insights 

GENIE enables robust analysis of both rare cancers and rare variants in common cancers, ensuring low-prevalence populations are accurately represented in precision oncology strategies.  

Platform-Based Data Solutions: A Scalable Model 

GENIE goes beyond standard data access by offering innovative platform-based services that empower partners to integrate and scale their RWD capabilities. 

• Platform-as-a-Service (PaaS): A turnkey solution for establishing legal governance and scalable data-sharing frameworks; ideal for non-profits and organizations seeking a proven, scalable model for data sharing and analysis. 
• Registry-as-a-Service (RaaS): Custom-built registries combining GENIE RWD with partner- or GENIE-provided data, supporting planned and ongoing clinical programs.

This modular and scalable approach allows industry partners to leverage the GENIE infrastructure while maintaining flexibility in their own data strategies.